Background: adults aged 80 and over, a fast growing age-group, with increased co-morbidity and frailty have not been the focus of previous research on dyspnoea. We investigate the correlates of dyspnoea and its association with adverse outcomes in a cohort of adults aged 80 and over. Methods: about 565 community-dwelling adults aged 80 and over of the BELFRAIL prospective cohort had assessment of Medical Research Council dyspnoea scale (MRC), forced expiratory volume in 1 s (FEV 1 ), N-terminal pro-brain natriuretic peptide (NT-proBNP), physical performance tests, grip strength, 15 items geriatric depression scale, activities of daily living (ADL), body mass index (BMI) and demographics data. Kaplan-Meier survival curves, Cox and logistic multivariable regression, classification and regression tree (CART) analysis assessed association of dyspnoea (MRC 3-5) with time-to-cardiovascular and allcause death (5 years), time to first hospitalisation (3 years), new/worsened ADL disability (2 years), and its correlates. Results: participants with dyspnoea MRC 3-5 (29.9%) had increased hazard ratios for cardiovascular mortality 2.85 (95% confidence interval 1.93-4.20), all-cause mortality 2.04 (1.58-2.64), first hospitalisation 1.72 (1.35-2.19); and increased odds ratio for new/worsened disability 2.49 (1.54-4.04), independent of age, sex and smoking status. Only FEV 1 , physical performance, BMI and NT-proBNP (in order of importance) were selected in the tree-based classification model for dyspnoea. Conclusions: in a cohort of adults aged 80 and over, dyspnoea was common and an independent predictor of adverse outcomes, with cardio-respiratory and physical performance impairments as key independent correlates. Its routine and comprehensive evaluation in primary care could be very valuable in caring for this age-group.
Introduction
Dyspnoea on exertion is a common and distressing symptom in older adults, with prevalence ranging from 16-36% [1] . Yet, it is a non-specific and complex symptom, especially in older adults where co-morbidity is frequent, subjective awareness of dyspnoea may be reduced, and it may be attributed to normal ageing [1] [2] [3] . In a recent systematic review on dyspnoea in older adults, only one study had investigated the causes of dyspnoea in a small sample of older adults aged 60-79 year, reporting an overlap between lung disease, heart disease, obesity and deconditioning [1, 4] .
The study of dyspnoea in older adults is important as it is a disabling symptom, with limitation of basic and instrumental activities of daily living, as well as mobility, and is associated with functional decline and frailty [2, [5] [6] [7] . Dyspnoea has also been found to be an independent predictor of all-cause mortality in community-dwelling older adults [8] [9] [10] . It is even reported to be a better predictor of all-cause and specificcause mortality than lung function measures in patients with chronic obstructive pulmonary disease or angina in patients with suspected coronary heart disease [11, 12] . These findings have led to the call for routine assessment for dyspnoea, as it is easy, provides very valuable clinical information and its management may improve the quality of life [13, 14] .
No studies so far have investigated dyspnoea and its predictive value for all-cause and cardiovascular mortality, as well as other relevant adverse outcomes such as functional decline in community-dwelling adults aged 80 and over. This is a fast growing age-group worldwide, with a high burden of co-morbidity and frailty, as well as a high use of medical resources [15, 16] .
The aim of this study is to investigate the prevalence and correlates of dyspnoea, as well as its association with all-cause and cardiovascular mortality, unplanned hospitalisation and new or worsened disability in a cohort of adults aged 80 and over.
Methods
Study design and population BELFRAIL is a prospective, observational, populationbased cohort study of people aged 80 years and over living in Belgium. The study protocol and sampling methods have been already published [16] . Between November 2008 to September 2009, in 29 general practice centres, 567 individuals aged 80 years and older were randomly recruited, excluding only those with severe dementia (known mini mental status exam score <15/30), in palliative care or medical emergencies. The study protocol was approved by the Biomedical Ethics Committee of the Medical School of the Université catholique de Louvain in Belgium. All participants gave informed consent.
Baseline dyspnoea
Dyspnoea was assessed with the Medical Research Council (MRC) scale (with an additional grade 0 if not troubled by dyspnoea) administered by the GPs at the baseline assessment [16] . This scale has been widely used in studies of dyspnoea in older adults [1, 9, 17] MRC grade 3 ('I walk slower than other people of same age on the level ground') categorised participants into those without/mild dyspnoea (0-2) and moderate-severe dyspnoea (3) (4) (5) [7] . In the rest of this paper, dyspnoea refers to MRC grade 3-5.
Outcome measurements
Time to all-cause and cardiovascular death, and first, unplanned hospitalisation were used as outcome measurements. The date and cause of hospitalisation (until 3.0 ± 0.25 years) and death (until 5.1 ± 0.2 years) were prospectively reported by the participants' general practitioners [16] .
Disability was assessed at baseline and follow-up by the degree of difficulty with six activities of daily living (ADL) (see Supplementary data, Appendix 1, available in Age and Ageing online for details), using the lowest quintile score (20) as a cut-off [16] . New or worsened disability was considered if those without disability at baseline became dependent at follow-up, or those dependent at baseline had a decreased follow-up score.
Demographic and clinical variables
In addition to age and sex, the following were considered as possible correlates of dyspnoea, based on previous research [4, 6, 7, [18] [19] [20] Spirometry was recorded by two trained clinical research assistants using a Spirobank spirometer (Medical International Research, Rome, Italy) without reversibility testing. Two independent researchers evaluated all spirograms based on the acceptability and repeatability criteria of the American Thoracic Society/European Respiratory Society [21] . Only individuals with usable spirograms were included in this study [21, 22] . FEV 1 was expressed as z-score derived from the Global Lung Function Initiative 2012 reference equations [23] . Low FEV 1 was defined as FEV 1 z-score <−1.645 [24] .
Serum NT-proBNP was measured with DadeDimension Xpand (Siemens, Deerfield, IL, USA) using serum samples of morning blood that were stored frozen at −80°C until analysis. High NT-proBNP was defined as NT-proBNP ≥400 pg/ml [25] . Physical performance was determined based on a battery of PPT and grip strength (see Supplementary data, Appendix 1, available in Age and Ageing online for details). Low physical performance was defined as being in the lowest sex-specific quintile of either the PPT score (4 for females; 7 for males) or grip strength (13.3 kg for females; 22.5 kg for males). The GDS-15 was used to screen for depression in the BELFRAIL cohort, and a score ≥5 identified participants at risk for depression [16] .
Statistical analysis
Logistic regression analysis and classification and regression tree (CART) analyses were used to investigate the potential demographic and clinical correlates of dyspnoea. Participants with missing FEV 1 z-score were compared for statistically significant differences in regard to study variables to those with available FEV 1 z-score.
Kaplan-Meier curves for all-cause, cardiovascular and non-cardiovascular mortality, and hospitalisation were plotted for the two dyspnoea categories, with log-rank test for comparison. The Cox proportional hazards regression analysis estimated the hazard ratio (HR) for all-cause and cardiovascular mortality, and unplanned hospitalisation. Odds ratios (ORs) for new/worsened disability were estimated with the logistic regression multivariable analysis. As there were participants with missing data on disability assessment at follow-up, sensitivity analysis was performed considering both worst (all those with missing data had new/worsened disability) and best (all had no new/worsened disability scenarios). Models were adjusted for age, sex and smoking status and stratified for BMI, FEV 1 , NT-proBNP and physical performance. They were checked for variable collinearity, linearity and proportionality assumptions. A twotailed probability value P < 0.05 was considered statistically significant. Statistical analysis was performed with SPSS 23.0 (SPSS Inc., Chicago, IL, USA).
Results

Baseline characteristics of the study population
Out of the 567 participants of the BELFRAIL cohort, 565 (99.6%) had MRC score at the baseline assessment and were considered as this study's population. They had a mean age of 84.7 years and consisted of 62.8% females. There were 126 (22.3%) participants who reported no dyspnoea; 118 (20.9%) were troubled by dyspnoea only on strenuous exercise (MRC 1); 152 (26.9%) when hurrying on level or walking up a slight hill (MRC 2); 60 (10.6%) had to walk slower than other people on the level ground (MRC 3); 89 (15.8%) had to stop for breath after walking about 100 m or after a few minutes on level ground (MRC 4); and only 20 (3.5%) participants were too breathless to leave the house or when getting undressed (MRC 5). Participants with dyspnoea (MRC 3-5), had higher BMI, lower FEV 1 , higher NTproBNP, higher GDS-15 scores, lower grip strength, ADL and PPT scores, as well as higher number of cardiovascular diseases and higher frequency of respiratory disease compared to those without dyspnoea (Table 1) . Participants with missing FEV1 z-score (44 did not perform spirometry, 21 had non-usable spirograms and 6 were older than 95 years, the age limit of reference equations) had no significant differences compared to those with available FEV 1 , except for a higher death rate (55.6% versus 40.8%) and dyspnoea prevalence (40.8% versus 28.3%).
Correlates of dyspnoea
The multivariable logistic regression analysis with all the possible dyspnoea correlates, showed that low FEV 1 
Association with adverse outcomes
Mortality data were available for all the participants. Hospitalisation data were available for 559 (98.9%) participants. During 3.0 ± 0.25 years follow-up, 288 (51.5%) had at least one unplanned hospitalisation, and at 5.1 ± 0.2 years 242 (42.8%) had died. Data on new/worsened ADL Figure 1 . Kaplan-Meier survival analysis curves of the two groups of dyspnoea for 5 years all-cause, cardiovascular and noncardiovascular mortality, and unplanned hospitalisation at 3 years follow-up. MRC: Medical Research Council dyspnoea scale. disability were available for 419 (74.2%) participants (72 had died before the second assessment, 60 refused it and 6 had incomplete ADL score). At 1.7 ± 0.21 years follow-up, 107 (25.5%) had new/worsened ADL disability. Kaplan-Meier survival curves showed a significantly lower proportion of those with dyspnoea surviving all-cause, cardiovascular and non-cardiovascular mortality at 5 years, and being without unplanned hospitalisation at 3 years follow-up (Figure 1) (Table 2 ). Both worst and best scenario analysis for the participants without follow-up ADL scores did not significantly change these findings.
The association of dyspnoea with all-cause and cardiovascular mortality, and unplanned hospitalisation was statistically significant for those with normal FEV 1 , normal or high NT-proBNP (except for all-cause mortality), normal physical performance and both BMI categories ( Table 2 ). The association with new/worsened disability was statistically significant for those with normal FEV 1 , normal NTproBNP or overweight/obese BMI ( Table 2) .
Discussion Main findings
In a cohort of adults aged 80 and over, nearly 30% reported dyspnoea MRC 3-5. Low FEV 1 , high NT-proBNP, low physical performance and high BMI were its key independent correlates. Dyspnoea in this cohort was associated with 5-years all-cause and cardiovascular mortality, first unplanned hospitalisation at 3 years, and new/worsened ADL disability at around 2 years follow-up, independently of age, sex and smoking status. These associations were significant even for those with normal FEV 1 , NT-proBNP, physical performance or BMI.
Prevalence and correlates of dyspnoea
Previous studies of dyspnoea in general populations of older adults have reported MRC 3-5 prevalence of 8.2-32.3% [1] . Only two studies reported age-stratified data, where prevalence for those aged 80 and over ranged [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] .3% for males and 35-43% for females [1] . In our representative cohort of adults aged 80 and over, 29.9% reported dyspnoea MRC 3-5.
Few studies have looked at correlates of dyspnoea MRC 3-5 in older adults, and none so far in those aged 80 and over [6, 20] . In a population-based cohort of adults aged 70 and over in Wales, dyspnoea MRC 3-5 (32.3% of the population) was associated with obesity, respiratory diseases, left ventricular systolic function, lower scores of an anxiety and depression scale, self-assessed health status, and mobility tasks of an ADL scale [6] . In the Cardiovascular Health Study cohort of older adults in the USA (13% were aged 80 and over), age, smoking status, hip and waist size, FEV 1 , forced vital capacity and presence of cardio-respiratory diseases were reported as independent correlates of dyspnoea MRC 3-5 (10.1% of the population) [20] . In our cohort of adults aged 80 and over, the CART analysis showed low FEV 1 , low physical performance, high NT-proBNP and BMI as independent correlates of dyspnoea.
Both FEV 1 as measure of respiratory disease and NTproBNP as measure of cardiovascular disease have been reported as providing important information about chronic dyspnoea, independent of clinical factors, in community-dwelling adults 45-84 years old [18] . Poor performance on a single chair stand test has also been reported as independently associated with moderate-severe dyspnoea in community-dwelling adults 65-80 years old [7] . We confirmed these findings in our cohort of adults aged 80 and over, using a broader measurement of physical performance (battery of PPT and grip strength). We found that low physical performance was strongly associated with dyspnoea independent of low FEV 1 and high NTproBNP. One suggested mechanism of the association between low physical performance and dyspnoea in older adults is through the age-related sarcopenia that includes weakness of ambulation and respiratory muscles [7] . Also, deconditioning due to low physical activity, which is further worsened by dyspnoea, may exacerbate the age-related sarcopenia and then dyspnoea on exertion [7] . These mechanisms, and interventions that modify either or both sarcopenia and dyspnoea, such as exercise programs, need to be further investigated [7, 26, 27] . Our findings in adults aged 80 and over emphasise the importance of a more comprehensive approach to the evaluation of dyspnoea in this age-group, looking beyond cardiorespiratory diagnoses and considering the multiple, age-related impairments that may influence dyspnoea [7, 17, 28, 29] .
Dyspnoea and adverse outcomes
Previous studies in older adults have reported dyspnoea as an independent predictor of all-cause mortality [8] [9] [10] . We extended these findings into adults aged 80 and over, and investigated association to unplanned hospitalisation and new/worsened disability that are more relevant outcomes for this age-group. We found that these associations were present, and for some outcomes event stronger, in participants with normal FEV 1 , NT-proBNP or physical performance. Thus, dyspnoea is a symptom that provides very valuable prognostic information regarding development of adverse outcomes in adults aged 80 and over, even in those with normal cardio-respiratory function or physical performance.
Our findings support the recent call for a systematic and routine assessment of dyspnoea in older adults, not only as a symptom of high burden chronic diseases such as cardiorespiratory ones, but also as a geriatric syndrome and potential marker of frailty and adverse outcomes [9, 13, 14] .
Pro-active evaluation for dyspnoea is particularly important in the older adults, as its perception and spontaneous report is reduced in this age-group [3, 14] . Previous research has reported poor early recognition of symptoms in older adults due to impaired awareness and interpretation of symptoms, including dyspnoea [30] . They may be unaware of its increasing severity due to altered sensory perception, become accustomed to it or assign it to 'normal' ageing [3, 30] .
Strengths and limitations
The strengths of this study are its prospective cohort design, with comprehensive and standardised assessments, and almost complete data on mortality and hospitalisation followup. Some of the limitations are the missing data on FEV 1 and ADL at follow-up. Yet, sensitivity analysis on the effect of these missing data did not show significant differences from the reported findings. We also used the MRC scale that measures only one dimension of dyspnoea, its impact, and not its sensory-perceptual and affective distress dimensions [2] . Although the MRC scale has been widely used in older adults, future research should consider multi-dimensional scales of dyspnoea, as well as its dynamics over time [1, 13] .
Conclusion
Nearly 30% of our representative cohort of adults aged 80 and over reported dyspnoea MRC 3-5 that was independently associated with higher risk for adverse outcomes and correlated to cardiopulmonary and physical performance impairments. As it is easy to assess and provides valuable clinical information for improving the focus and prioritisation of care, dyspnoea should be actively searched for and managed as a multi-factorial symptom in this age-group.
Key points
• Nearly 30% of our representative cohort of adults aged 80 and over reported dyspnoea MRC 3-5.
• Dyspnoea was independently associated with higher risk for mortality, hospitalisation and disability.
• Cardiopulmonary and physical performance impairments were the main independent correlates of dyspnoea.
• Dyspnoea is not only a symptom of common cardiorespiratory diseases but also a potential marker of frailty and adverse outcomes.
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